1. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis
   Warangkana Lohcharoenkal et al, 2018, Journal of Investigative Dermatology CrossRef
2. Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo
   Paul A. Keire et al, 2016, Matrix Biology CrossRef
3. miR-124 inhibits proliferation, migration and invasion of malignant melanoma cells via targeting versican
   Ping Yang et al, 2017, Experimental and Therapeutic Medicine CrossRef
4. MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells
   NAOTAKE FUNAMIZU et al, 2015, International Journal of Oncology CrossRef
5. Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma
   Mari Poukka et al, 2016, BMC Cancer CrossRef
6. RAB22A overexpression promotes the tumor growth of melanoma
   Feng Su et al, 2016, Oncotarget CrossRef
7. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma
   Natalia García-Sancha et al, 2019, International Journal of Molecular Sciences CrossRef
8. miRNAs in melanoma: a defined role in tumor progression and metastasis
   Francesco Mannavola et al, 2016, Expert Review of Clinical Immunology CrossRef
9. MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3′-UTR
   Xue Zhao et al, 2017, Cancer Biomarkers CrossRef
10. A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products
    Keke Li et al, 2020, Cancer Cell International CrossRef
11. Pivotal MicroRNAs in Melanoma: A Mini-Review
    Zhenjun Deng et al, 2016, Molecular Diagnosis & Therapy CrossRef
12. MicroRNAs in melanocyte and melanoma biology
    Marina Mione et al, 2015, Pigment Cell & Melanoma Research CrossRef
13. Importance of microRNAs in Skin Oncogenesis and Their Suitability as Agents and Targets for Topical Therapy
    Dennis Gerloff et al, 2020, Skin Pharmacology and Physiology CrossRef
14. A Role for Versican in the Development of Leiomyosarcoma
    Paul A. Keire et al, 2014, Journal of Biological Chemistry CrossRef
15. miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells
    Mariko Mine et al, 2015, PLOS ONE CrossRef
16. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling
    Nidhi Gupta et al, 2020, RNA Biology CrossRef
17. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma
    Nidhi Gupta et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
18. MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
    Soudeh Ghafouri-Fard et al, 2021, Frontiers in Oncology CrossRef
19. MiRNAs in Malignant Melanoma
    Maria Mione et al, 2017, Melanoma Development CrossRef
20. Epigenetic inactivation of miR-203 as a key step in neural crest epithelial-to-mesenchymal transition
    Estefanía Sánchez-Vásquez et al, 2019, Development CrossRef
21. Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma
    Kathleen Watt et al, 2020, Translational Oncology CrossRef
22. MicroRNA-18b inhibits the growth of malignant melanoma via inhibition of HIF-1α-mediated glycolysis
    YAO CHEN et al, 2016, Oncology Reports CrossRef
23. Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles
    Natasha McRae et al, 2017, International Journal of Molecular Sciences CrossRef